Catalyst Capital Advisors LLC held its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,400 shares of the healthcare conglomerate’s stock at the end of the 2nd quarter. Catalyst Capital Advisors LLC’s holdings in UnitedHealth Group were worth $260,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the company. State Street Corp increased its position in shares of UnitedHealth Group by 2.5% during the first quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock worth $7,499,276,000 after acquiring an additional 1,122,534 shares in the last quarter. Legal & General Group Plc increased its position in shares of UnitedHealth Group by 5.4% during the first quarter. Legal & General Group Plc now owns 4,954,692 shares of the healthcare conglomerate’s stock worth $812,630,000 after acquiring an additional 254,545 shares in the last quarter. Harris Associates L P increased its position in shares of UnitedHealth Group by 0.3% during the first quarter. Harris Associates L P now owns 4,646,307 shares of the healthcare conglomerate’s stock worth $762,041,000 after acquiring an additional 14,489 shares in the last quarter. Longview Partners Guernsey LTD increased its position in shares of UnitedHealth Group by 3.5% during the second quarter. Longview Partners Guernsey LTD now owns 4,510,545 shares of the healthcare conglomerate’s stock worth $836,345,000 after acquiring an additional 151,208 shares in the last quarter. Finally, UBS Asset Management Americas Inc. increased its position in shares of UnitedHealth Group by 6.2% during the first quarter. UBS Asset Management Americas Inc. now owns 4,372,898 shares of the healthcare conglomerate’s stock worth $717,199,000 after acquiring an additional 255,799 shares in the last quarter. 86.19% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This article was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another website, it was stolen and republished in violation of international copyright laws. The correct version of this article can be accessed at https://www.thecerbatgem.com/2017/10/13/unitedhealth-group-incorporated-unh-position-maintained-by-catalyst-capital-advisors-llc.html.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the sale, the director now owns 76,058 shares in the company, valued at $14,753,730.84. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the sale, the director now owns 60,834 shares in the company, valued at approximately $12,135,774.66. The disclosure for this sale can be found here. Insiders have sold 76,174 shares of company stock worth $14,981,909 in the last ninety days. Insiders own 0.89% of the company’s stock.

Several research firms recently weighed in on UNH. ValuEngine cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Cantor Fitzgerald restated a “buy” rating on shares of UnitedHealth Group in a report on Tuesday, August 29th. Sanford C. Bernstein restated an “outperform” rating and set a $210.00 price target on shares of UnitedHealth Group in a report on Tuesday. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday. Finally, UBS AG restated an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, August 24th. Three equities research analysts have rated the stock with a hold rating and twenty-three have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $203.59.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating the consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business had revenue of $50.05 billion for the quarter, compared to the consensus estimate of $49.97 billion. During the same quarter in the previous year, the firm earned $1.96 earnings per share. The company’s revenue for the quarter was up 7.7% on a year-over-year basis.

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th were issued a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.56%. The ex-dividend date of this dividend was Thursday, September 7th. UnitedHealth Group’s dividend payout ratio is currently 35.13%.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.